Search Results - "Yélamos, J"

Refine Results
  1. 1

    PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors by Farrés, J, Llacuna, L, Martin-Caballero, J, Martínez, C, Lozano, J J, Ampurdanés, C, López-Contreras, A J, Florensa, L, Navarro, J, Ottina, E, Dantzer, F, Schreiber, V, Villunger, A, Fernández-Capetillo, O, Yélamos, J

    Published in Cell death and differentiation (01-07-2015)
    “…Erythropoiesis is a tightly regulated process in which multipotential hematopoietic stem cells produce mature red blood cells. Here we show that deletion of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Therapeutic treatment with poly(ADP‐ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury by Mota, R, Sánchez‐Bueno, F, Berenguer‐Pina, J J, Hernández‐Espinosa, D, Parrilla, P, Yélamos, J

    Published in British journal of pharmacology (01-08-2007)
    “…Background and purpose: The mortality associated with acute pancreatitis (AP) is largely attributable to abnormalities that occur in distant organs and…”
    Get full text
    Journal Article
  4. 4

    In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin by HERNÁNDEZ‐ESPINOSA, D., MOTA, R., MIÑANO, A., ORDÓÑEZ, A., YÉLAMOS, J., VICENTE, V., CORRAL, J.

    Published in Journal of thrombosis and haemostasis (01-05-2007)
    “…Background: High temperatures produce in vitro transitions of antithrombin to its inactive latent and polymeric forms. Accordingly, high body temperatures…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement by Giménez‐Arnau, A., Curto‐Barredo, L., Nonell, L., Puigdecanet, E., Yelamos, J., Gimeno, R., Rüberg, S., Santamaria‐Babi, L., Pujol, R.M.

    Published in Allergy (Copenhagen) (01-11-2017)
    “…Background The knowledge about chronic spontaneous urticaria (CSU) phenotypes is based on its clinical characteristics, associated comorbidities, course of the…”
    Get full text
    Journal Article
  7. 7

    Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer by Rojo, F., García-Parra, J., Zazo, S., Tusquets, I., Ferrer-Lozano, J., Menendez, S., Eroles, P., Chamizo, C., Servitja, S., Ramírez-Merino, N., Lobo, F., Bellosillo, B., Corominas, J.M., Yelamos, J., Serrano, S., Lluch, A., Rovira, A., Albanell, J.

    Published in Annals of oncology (01-05-2012)
    “…Poly(ADP-ribose)polymerase-1 (PARP-1) is a highly promising novel target in breast cancer. However, the expression of PARP-1 protein in breast cancer and its…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Inhibition of apoptosis of a PARP −/ − cell line transfected with PARP DNA-binding domain mutants by Aoufouchi, S, Yélamos, J, Milstein, C

    Published in Journal of molecular biology (30-07-1999)
    “…We have investigated the possibility of the involvement of PARP in apoptosis, independently of its enzymatic activity. We thus transfected PARP −/ − A11 cells…”
    Get full text
    Journal Article
  11. 11

    Severe perioperative anaphylaxis: Incidence in a tertiary hospital in Spain over a 20-year period. A historical cohort study by Escolano, F., Yelamos, J., Moltó, L., Fort, B., Espona, M., Giménez-Arnau, A.

    “…To assess the incidence of severe perioperative anaphylaxis, the mechanisms involved, the value of laboratory/skin tests, and the most effective treatments. A…”
    Get full text
    Journal Article
  12. 12

    Circulating NK‐Cell Subsets in Renal Allograft Recipients With Anti‐HLA Donor‐Specific Antibodies by Crespo, M., Yelamos, J., Redondo, D., Muntasell, A., Perez‐Saéz, M. J., López‐Montañés, M., García, C., Torio, A., Mir, M., Hernández, J. J., López‐Botet, M., Pascual, J.

    Published in American journal of transplantation (01-03-2015)
    “…Detection of posttransplant donor‐specific anti‐HLA antibodies (DSA) constitutes a risk factor for kidney allograft loss. Together with complement activation,…”
    Get full text
    Journal Article
  13. 13

    Loss of PIDD limits NF-κB activation and cytokine production but not cell survival or transformation after DNA damage by Bock, F J, Krumschnabel, G, Manzl, C, Peintner, L, Tanzer, M C, Hermann-Kleiter, N, Baier, G, Llacuna, L, Yelamos, J, Villunger, A

    Published in Cell death and differentiation (01-04-2013)
    “…Activation of NF- κ B (nuclear factor of kappa light chain gene enhancer in B cells) in response to DNA damage is considered to contribute to repair of genetic…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice by Nicolás, L, Martínez, C, Baró, C, Rodríguez, M, Baroja-Mazo, A, Sole, F, Flores, J M, Ampurdanés, C, Dantzer, F, Martin-Caballero, J, Aparicio, P, Yelamos, J

    Published in Oncogene (13-05-2010)
    “…Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl)ation of proteins. Parp-2 deficiency in mice (Parp-2 −/− )…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20